Hikma Pharmaceuticals stock gains 8.7 percent year to date
Published on 09/22/2026 at 19:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Hikma Pharmaceuticals Plc (GB00B128J450) closed at 1,611.0 pence on the London Stock Exchange on September 21, 2026, after a 0.69 percent daily gain. The shares were 9 percent below their 52-week high, 41.5 percent above their 52-week low and 8.7 percent higher year to date.
Seven sessions of gains
The latest close extended Hikma stock's winning run to seven sessions, the longest such streak since 2023, according to AskTraders on September 21, 2026. Trading ranged from 1,585 pence to 1,630 pence, while volume reached 307,519 shares against a 20-day average of 516,861.
The numerical picture is mixed rather than one-directional. A year-to-date gain of 8.7 percent sits alongside a 9 percent gap to the annual high, showing that the recovery has not yet returned the stock to its top level.
R&D event sets next checkpoint
Hikma announced an R&D Investor Spotlight Series on September 22, 2026, according to Reuters. The event places research and development strategy at the center of the near-term investor narrative.
The company also scheduled its next trading update for November 5, 2026, according to Investing.com. That date gives the market a defined checkpoint for assessing operational progress after the September R&D sessions.
Stock remains below yearly peak
Hikma's market capitalization stood at GBP 3.2 billion on September 21, 2026, while the stock remained 41.5 percent above its 52-week low. The combination of an 8.7 percent year-to-date advance and a 9 percent distance from the high leaves the shares between recovery and full breakout territory.
Hikma stock closed at 1,611.0 pence on the London Stock Exchange on September 21, 2026, with a 0.69 percent daily increase. The next scheduled trading update is November 5, 2026.
Hikma Pharmaceuticals stock facts
- Company: Hikma Pharmaceuticals Plc
- ISIN: GB00B128J450
- Ticker: HIK
- Trading venue: London Stock Exchange
- Price as of September 21, 2026: 1,611.0 pence
- Market capitalization: GBP 3.2 billion as of September 21, 2026
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: FTSE 350
- Next earnings date: November 5, 2026
